Neos Therapeutics Slides Despite FDA Approval
Neos Therapeutics saw its shares dip on Tuesday even thought it received approval from the FDA for its treatment of ADHD.
All Work
Chris Lange
Chipotle Sinks on Updated Guidance
Chipotle Mexican Grill saw its shares drop on Tuesday after this burrito chain disclosed a downbeat sales outlook for the year. Ultimately, this guidance was not up to expectations, and Chipotle saw one of…
What to Expect From Red Hat Earnings
Red Hat is scheduled to release its most recent quarterly results after the markets close on Tuesday.
Egalet Stumbles Over FDA Complete Response Letter
Egalet saw its shares take a dive early on Tuesday after the company announced that it received a complete response letter FDA in regards to its chronic pain treatment.
Dova Pharmaceuticals Closes in on IPO
Dova Pharmaceuticals intends to price its about 4 million shares in the range of $15 to $17 in an initial offering valued up to more than $79 million.
Akcea Therapeutics Announces Potential Pricing for IPO
Akcea Therapeutics expects to price more than 9 million shares in the range of $12 to $14 apiece in an initial public offering valued up to almost $155 million.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was an incredibly positive day for the markets with the Dow and S&P 500 hitting all-time highs in the session and the Nasdaq having one of its best trading days this year. Although…
Snapchat Snags Clutch $100 Million Deal With Time Warner
Snapchat shares saw a slight uptick on Monday after it was reported that the mobile photo messaging service had inked a deal with Time Warnerand Warner Bros. studio.
Why Argus Is the Only Firm Defending Kroger
Things seems very bleak for the largest pure play grocer in the United States, but one independent research firm is coming to its defense.
Rigel Pharma Rises Following FDA Approval
Rigel Pharmaceuticals watched its shares make a handy uptick on Monday after the FDA approved its New Drug Application for the use of Tavalisse in patients with chronic or persistent immune thrombocytopenia.
Byline Bancorp Closes in on IPO After Announcing Potential Pricing
Byline Bancorp intends to price more than 5 million shares in the range of $19 to $21 apiece in an initial public offering valued up to more than $137 million.
Is This the Buyout Novadaq Needs?
Novadaq Technologies watched its shares practically double to kick off the week after the firm announced that it would be acquired by Striker.
Clovis Oncology Surges on Clutch Late-Stage Ovarian Cancer Trial
Clovis Oncology saw its shares make a massive gain early on Monday after the company announced top-line data from its confirmatory Phase 3 trial of its treatment of ovarian cancer.
Oracle, FedEx and More Earnings Coming Out This Week
24/7 Wall St. has put together a preview FedEx, Oracle and a few other major companies scheduled to report their quarterly results this coming week.
What This Whole Foods Acquisition Means for Walmart and the Rest of the Industry
24/7 Wall St. has taken a look at the earth-shattering events from the past week in the grocery space and given some analysis on how this might impact the rest of the industry.
Can Starbucks Keep Pace With the Market for the Rest of 2017?
Starbucks has more or less kept pace with the broad markets over the course of 2017. Although the year is nearly halfway over, can this coffee giant continue to keep pace with the markets?
Finisar Wins Big on Mixed Earnings and Guidance
Finisar reported mixed fiscal fourth-quarter financial results after the markets closed on Thursday.
Boston Omaha Quietly Enters the Market in IPO
Boston Omaha entered the market quietly on Friday in its initial public offering. Shares opened more or less in line with the expected price.
Aurinia Pharma Rises Following Updated Mid-Stage Results
Shares of Aurinia Pharmaceuticals saw a handy gain on Friday after the firm presented new data from its mid-stage study in lupus nephritis during the Annual European Congress of Rheumatology.
How Amazon Buyout of Whole Foods Challenges Wal-Mart
Whole Foods shares were halted in early trading Friday after some Earth-shattering news hit the market. Amazon.com is making an incredibly ambitious purchase and buying out the organic grocer.